NPI: 1417920034 · TUCSON, AZ 85710 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/13/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/13/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 26,566 | $702K |
| 2019 | 25,161 | $786K |
| 2020 | 26,225 | $958K |
| 2021 | 23,155 | $878K |
| 2022 | 18,646 | $631K |
| 2023 | 15,571 | $592K |
| 2024 | 9,115 | $472K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 55,292 | 4,334 | $4.31M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 29,046 | 2,197 | $384K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 630 | 372 | $276K |
| J1756 | Injection, iron sucrose, 1 mg | 8,814 | 2,216 | $49K |
| A4657 | Syringe, with or without needle, each | 16,535 | 2,900 | $61.95 |
| J1270 | Injection, doxercalciferol, 1 mcg | 16,258 | 1,365 | $4.61 |
| 83970 | 1,093 | 949 | $2.74 | |
| 82728 | 1,024 | 891 | $0.96 | |
| 83550 | 908 | 796 | $0.54 | |
| 83540 | 1,015 | 890 | $0.45 | |
| 85041 | 1,403 | 1,241 | $0.21 | |
| 85048 | 1,407 | 1,240 | $0.18 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 249 | 218 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 316 | 211 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 169 | 154 | $0.00 |
| 0064A | 18 | 17 | $0.00 | |
| 90674 | 150 | 135 | $0.00 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 58 | 24 | $0.00 |
| 0012A | 20 | 15 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 9,389 | 751 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 276 | 36 | $0.00 |
| 82108 | 348 | 304 | $0.00 | |
| 0124A | 21 | 21 | $0.00 |